Haihong Chen

Title: Innovations by Haihong Chen in Glyburide Formulation

Introduction

Haihong Chen is an accomplished inventor based in Acton, MA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of a low-sorbing glyburide formulation. His work aims to enhance the stability and delivery of glyburide, a medication used to treat type 2 diabetes.

Latest Patents

Haihong Chen holds a patent for a "Low-sorbing glyburide formulation and methods." This patent focuses on methods and formulations that minimize or avoid the sorption of glyburide to surfaces of delivery tubing, filters, bags, and other containers. The innovation ensures the storage and delivery of a more stable product, providing a predictable and accurate dose of glyburide. It also aims to minimize impurities, avoid drug waste, reduce costs, and significantly decrease the amount of dosing solution that must be infused into the patient. He has 1 patent to his name.

Career Highlights

Chen is currently employed at Remedy Pharmaceuticals, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in drug formulation has positioned him as a valuable asset to his team and the company.

Collaborations

Some of his notable coworkers include Kenny K Tran and Deirdre Lowe, who contribute to the collaborative environment at Remedy Pharmaceuticals, Inc. Their combined efforts enhance the research and development of effective pharmaceutical solutions.

Conclusion

Haihong Chen's innovative work in glyburide formulation exemplifies the impact of targeted research in the pharmaceutical industry. His contributions not only improve drug delivery but also enhance patient care through more effective treatment options.